Sitagliptin phosphate monohydrate, metformin hydrochloride
Key facts
| Invented name |
Efficib
|
| Active substance |
|
| Therapeutic area |
Endocrinology, -gynacology-fertility-metabolism
|
| Decision number |
P/117/2008
|
| PIP number |
Sitagliptin phosphate monohydrate, metformin hydrochloride
|
| Pharmaceutical form(s) |
Film-coated tablet
|
| Condition(s) / indication(s) |
Treatment of type II diabetes mellitus
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Merck Sharp and Dohme (Europe), Inc.
|
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|